Debrief
发表于 2025-3-23 12:34:20
http://reply.papertrans.cn/88/8764/876357/876357_11.png
Generator
发表于 2025-3-23 17:20:14
Richard K. Burdick,David J. LeBlond,Lori B. Pfahler,Jorge Quiroz,Leslie Sidor,Kimberly Vukovinsky,La
雕镂
发表于 2025-3-23 20:04:01
http://reply.papertrans.cn/88/8764/876357/876357_13.png
外来
发表于 2025-3-24 02:12:53
http://reply.papertrans.cn/88/8764/876357/876357_14.png
Accolade
发表于 2025-3-24 05:20:43
http://reply.papertrans.cn/88/8764/876357/876357_15.png
正式通知
发表于 2025-3-24 06:59:17
Process Qualification: Stage 2 of the FDA Process Validation Guidance,sing experimental design. The resulting process design experiments yield information that can be used to define future operating ranges for the new process. The second stage of process validation is process qualification.
摆动
发表于 2025-3-24 14:34:49
http://reply.papertrans.cn/88/8764/876357/876357_17.png
ANIM
发表于 2025-3-24 18:14:57
http://reply.papertrans.cn/88/8764/876357/876357_18.png
猛击
发表于 2025-3-24 21:10:17
Process Design: Stage 1 of the FDA Process Validation Guidance,This is the first of three chapters that describe statistical approaches related to the three stages of process validation described in the FDA Process Validation Guidance for Industry (2011). The three stages are
鼓掌
发表于 2025-3-25 01:29:40
http://reply.papertrans.cn/88/8764/876357/876357_20.png